Back
Denali Therapeutics Vs. Armata Pharmaceuticals Industry Stock Comparison
Buy
60
DNLI
Denali Therapeutics
Last Price:
28.41
Seasonality Move:
6.34%
Buy
87
ARMP
Armata Pharmaceuticals
Last Price:
2.69
Seasonality Move:
12.82%
Buy
60
Denali Therapeutics (DNLI)
is a Buy
Is Denali Therapeutics a Buy, Sell or Hold?
- The current Denali Therapeutics [DNLI] share price is $29.64. The Score for DNLI is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
- DNLI is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
87
Armata Pharmaceuticals (ARMP)
is a Buy
Is Armata Pharmaceuticals a Buy, Sell or Hold?
- The current Armata Pharmaceuticals [ARMP] share price is $2.72. The Score for ARMP is 87, which is 74% above its historic median score of 50, and infers lower risk than normal.
- ARMP is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
DNLI Stock Price Chart
What is Denali Therapeutics's stock price today?
-
The Denali Therapeutics share price today is $29.64
The current trend is moderately bearish and DNLI is experiencing selling pressure, which indicates risk of future bearish movement.
ARMP Stock Price Chart
What is Armata Pharmaceuticals's stock price today?
-
The Armata Pharmaceuticals share price today is $2.72
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ARMP is experiencing selling pressure, which indicates risk of future bearish movement.
DNLI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.78 | Buy |
| Relative Strength Index (14 RSI): | 57.2 | Buy |
| Chaikin Money Flow: | -842351 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (26.07 - 29.31) | Buy |
| Bollinger Bands (100): | (22.66 - 28.54) | Buy |
ARMP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.04 | Buy |
| Relative Strength Index (14 RSI): | 67.14 | Buy |
| Chaikin Money Flow: | -21890 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.24 - 2.48) | Buy |
| Bollinger Bands (100): | (2.25 - 2.77) | Buy |
DNLI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 29.56 | Buy |
| 20-day SMA: | 27.91 | Buy |
| 50-day SMA: | 28.09 | Buy |
| 200-day SMA: | 22.26 | Buy |
| 8-day EMA: | 29.55 | Buy |
| 20-day EMA: | 28.55 | Buy |
| 50-day EMA: | 27.49 | Buy |
| 200-day EMA: | 24.13 | Buy |
ARMP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.39 | Buy |
| 20-day SMA: | 2.37 | Buy |
| 50-day SMA: | 2.34 | Buy |
| 200-day SMA: | 2.84 | Sell |
| 8-day EMA: | 2.46 | Buy |
| 20-day EMA: | 2.39 | Buy |
| 50-day EMA: | 2.39 | Buy |
| 200-day EMA: | 2.63 | Buy |
Denali Therapeutics Earnings Growth & DNLI Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.78 per share, and a decrease next year of $0.10 per share.
Armata Pharmaceuticals Earnings Growth & ARMP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.01 per share, and an increase next year of $0.52 per share.
Denali Therapeutics Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Armata Pharmaceuticals Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||